Here are five key notes on the sale:
• Mr. Hannon sold 1,822 shares
• Average price per share was $47.99
• The total transaction was $87,438
• The transaction occurred on Feb. 23
• NuVasive ended the trading session with a loss of 1.08 points
According to the report, heavy selling caused a price collapse intraday to $44.3905 from the previous close at $45.75. Value-buying helped the shares pare some of the losses, but they still dipped negatively at the end of the day.
NuVasive has a $2 billion market cap and more than 48 million outstanding shares. The 52-week high is $51.23.
More articles on orthopedic devices:
LDR short interest up by 7.8% — 5 quick notes
6 key notes on Mazor Robotics’ short interest decline
SI-BONE reaches 15k iFuse procedures—5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
